Tewksbury Psychiatry and Ketamine

Tewksbury Psychiatry and Ketamine in Tewksbury, Massachusetts offers FDA-approved Spravato (esketamine) and ketamine treatment for adults with treatment-resistant depression and major depressive disorder with suicidal thoughts. Both therapies target the brain's glutamate system rather than serotonin, helping restore neural connections and improve mood within hours to days rather than weeks.
Spravato is administered in-clinic as a nasal spray, with no IV or needles, followed by a two-hour monitoring period. Candidates typically have tried two or more antidepressants without success and are under the care of a psychiatrist or mental health provider. The clinic offers a free eligibility screening and verifies insurance coverage.
A local, physician-led practice rather than a chain, Tewksbury Psychiatry and Ketamine provides safe, monitored, evidence-based care for treatment-resistant depression, major depressive disorder, anxiety with depressive symptoms, PTSD on a case-by-case basis, and suicidal ideation associated with MDD. The clinic serves patients across Tewksbury, Lowell, and Andover.
Spravato® (esketamine)
Used for:
Treatment details are based on information published by the clinic, checked in August 2026.
Clinic-wide information; ask which treatments are appropriate for you.
Accepts insurance
Most insurance plans may cover Spravato® (insurance verification available)
Contact clinic for pricing.
Send your details to Tewksbury Psychiatry and Ketamine and they can reach out to you directly.
Is this your clinic?
Keep your clinic information up to date. Claim your free listing to manage your services, pricing, and photos.
Online management is opening gradually. You can still send us corrections for free.
Request a Free Listing UpdateWant more visibility?
Get priority placement on your state page, a gold badge, and up to five photos with Featured. Featured is paid advertising, not a clinical endorsement.
Get FeaturedThe free Verified badge links to your directory listing. It is separate from paid Featured placement and does not certify clinical quality or ownership.